Mike Dorato

Dr. Dorato has over 40 years of experience as a researcher and global leader of safety and efficacy in the pharmaceutical and CRO industries. Prior to joining BASi in May 2019 as part of the Smithers Avanza Toxicology Services acquisition, he was Executive Vice President of Toxicology Services (Smithers Avanza Toxicology Services, 5 years), Vice President and CSO Global Discovery Services (Covance, 5 years) and Executive Director Toxicology and Greenfield Laboratories Site Head (Eli Lilly and Co., 30 years). In these positions, he led global organizations in safety and efficacy lead optimization, investigative and regulatory toxicology, discovery and late phase pathology, animal welfare, molecular and anatomical imaging, in vivo pharmacology, developmental and reproductive toxicology, veterinary medicine and model development. Dr. Dorato is a member of SOT and ACT and is active as a mentor for new professionals. He has had adjunct professorships at St. John’s University and Butler University, and is a Visiting Scholar at St. John’s University.